FR2804436B1 - PROTEINE DE FUSION scsCNTFR/NNT-1 - Google Patents

PROTEINE DE FUSION scsCNTFR/NNT-1

Info

Publication number: FR2804436B1
Authority: FR; France
Prior art keywords: scscntfr; nnt; fusion protein; fusion; protein
Prior art date: 2000-01-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0013090A

Other languages

English (en)

Other versions

FR2804436A1 (fr

Inventor

Greg Elson

Jean Francois Gauchat

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Medicament SA

Original Assignee

Pierre Fabre Medicament SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-27

Filing date

2000-10-12

Publication date

2002-08-02

2000-01-27 Priority claimed from FR0001035A external-priority patent/FR2804434A1/fr

2000-10-12 Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA

2000-10-12 Priority to FR0013090A priority Critical patent/FR2804436B1/fr

2001-01-26 Priority to AU2001231918A priority patent/AU2001231918A1/en

2001-01-26 Priority to PCT/FR2001/000254 priority patent/WO2001055219A2/fr

2001-08-03 Publication of FR2804436A1 publication Critical patent/FR2804436A1/fr

2002-08-02 Application granted granted Critical

2002-08-02 Publication of FR2804436B1 publication Critical patent/FR2804436B1/fr

2020-10-12 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Cell Biology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

FR0013090A 2000-01-27 2000-10-12 PROTEINE DE FUSION scsCNTFR/NNT-1 Expired - Fee Related FR2804436B1 (fr)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
FR0013090A FR2804436B1 (fr)	2000-01-27	2000-10-12	PROTEINE DE FUSION scsCNTFR/NNT-1
AU2001231918A AU2001231918A1 (en)	2000-01-27	2001-01-26	Scscntfr/nnt-1 fusion protein
PCT/FR2001/000254 WO2001055219A2 (fr)	2000-01-27	2001-01-26	PROTEINE DE FUSION scsCNTFR/NNT-1

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0001035A FR2804434A1 (fr)	2000-01-27	2000-01-27	Heterocomplexe nnt-1/clf-1 et son utilisation en tant qu'activateur du recepteur complexe cntrfalpha/gp130/lifrbet a
FR0013090A FR2804436B1 (fr)	2000-01-27	2000-10-12	PROTEINE DE FUSION scsCNTFR/NNT-1

Publications (2)

Publication Number	Publication Date
FR2804436A1 FR2804436A1 (fr)	2001-08-03
FR2804436B1 true FR2804436B1 (fr)	2002-08-02

Family

ID=26212129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0013090A Expired - Fee Related FR2804436B1 (fr)	2000-01-27	2000-10-12	PROTEINE DE FUSION scsCNTFR/NNT-1

Country Status (3)

Country	Link
AU (1)	AU2001231918A1 (fr)
FR (1)	FR2804436B1 (fr)
WO (1)	WO2001055219A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0977859B1 (fr) *	1997-02-03	2004-08-11	Amgen Inc.,	Facteur neurotrophique nnt-1
WO1999000415A1 (fr) *	1997-06-30	1999-01-07	Human Genome Sciences, Inc.	Cytokine de type cardiotrophine

2000
- 2000-10-12 FR FR0013090A patent/FR2804436B1/fr not_active Expired - Fee Related
2001
- 2001-01-26 AU AU2001231918A patent/AU2001231918A1/en not_active Abandoned
- 2001-01-26 WO PCT/FR2001/000254 patent/WO2001055219A2/fr active Application Filing

Also Published As

Publication number	Publication date
WO2001055219A2 (fr)	2001-08-02
AU2001231918A1 (en)	2001-08-07
WO2001055219A3 (fr)	2002-03-07
FR2804436A1 (fr)	2001-08-03

Publication	Publication Date	Title
DK2236152T3 (da)	2014-07-07	Albuminfusionsproteiner
CY2014040I2 (el)	2016-04-13	Πρωτεϊνη συντηξης αλβουμινης
DE60144099D1 (de)	2011-04-07	Tripode-gleichlaufgelenk
ATE322251T1 (de)	2006-04-15	Neurotoxin implantat
DE60126129D1 (de)	2007-03-08	Interphalangärer gelenkersatz
DE60140664D1 (de)	2010-01-14	Schweisssystem
FR2800817B1 (fr)	2005-02-04	Joint homocinetique tripode
IT1313881B1 (it)	2002-09-24	Giunto omocinetico
DE60107387D1 (de)	2004-12-30	Tripodes gleichlaufgelenk
ATE439376T1 (de)	2009-08-15	Gag-bindende proteine
ID29577A (id)	2001-09-06	Protein pestisida
FR2809146B1 (fr)	2005-10-07	Joint homocinetique
DE60116130D1 (de)	2006-01-26	Tripode-gleichlaufgelenk
NO20021275D0 (no)	2002-03-14	Transgent produserte fusjonsproteiner
FR2840375B1 (fr)	2006-03-31	Joint homocinetique tripode
EP1018551A4 (fr)	2003-07-23	Proteine megsine
DE50102987D1 (de)	2004-09-02	Gelenkhalterung
DE10082298D2 (de)	2001-11-08	Chimäre Proteine
FI991256A0 (fi)	1999-06-02	Apulaite tarjoilua varten
ATE368115T1 (de)	2007-08-15	Bakterielle insektizidproteine
NO20021244D0 (no)	2002-03-13	Subenhet-optimaliserte fusjonsproteiner
DE60117001D1 (de)	2006-04-13	Nectin-3 proteine
FR2804436B1 (fr)	2002-08-02	PROTEINE DE FUSION scsCNTFR/NNT-1
DE10084565T1 (de)	2002-06-06	Verbindungsorgan
EP1209231A4 (fr)	2003-01-15	Proteine meg-1

Legal Events

Date	Code	Title	Description
2003-08-15	ST	Notification of lapse